Neurodegeneration – Webinars and Online Events

In this webinar, our speaker will discuss the role of glucosyl and galactosyl ceramides as biomarkers and how their misregulation can be an identifier for various disease states including, but not limited to, Parkinson’s, Krabbe and Gaucher diseases.

Dr. Walker explores how multi-modal biomarkers—from proteomics to brain imaging—can reveal blood-based indicators and therapeutic targets in individuals who later develop dementia.

This popular online event will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

bit.bio’s first-of-its-kind precision cellular reprogramming technology, opti-ox™, addresses the limitations of lot consistency, cell definition and scalability by controlling the precise expression of cell-fate determining genetic factors.

We will introduce the National Institutes of Health (NIH) Center for Alzheimer’s and Related Dementias (CARD) long-read sequencing initiative, which will generate a new genetic resource for Alzheimer’s and related dementias from thousands of human brain samples.

In this webinar, Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.

This online symposium will explore the tools and techniques being used to study diseases in the lab. Focus will be given to cell culture, organs-on-chips and key modeling strategies, as well as how research advances are enabling researchers to elucidate the underlying biological mechanisms of disease and support diagnostic and therapeutic development.

Alzheimer’s disease is the most common form of neurodegenerative disease, estimated to contribute to 60–70% of all cases of dementia worldwide. Increasing evidence suggests that neuroinflammation, primarily mediated by microglia, contributes to the onset and progression of Alzheimer’s disease.

In order to generate a genomic atlas of protein levels in neurologically relevant tissues, Dr. Carlos Cruchaga and his team profiled thousands of proteins, and performed bioinformatic analyses to determine if any of the identified proteins are drugable.

Returning for its third year, this online symposium will once again bring together leading scientists in the field as they highlight the latest advancements in translational proteomics and metabolomics. From uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.